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Background
Current first-line drugs for the treatment of tuberculosis
consist of, i.e., isoniazid (INH), rifampin (RIF), ethambutol
(EMB), pyrazinamide (PZA), and streptomycin (STR).
Resistance to the first-line drugs causes treatment failure
and necessitates the use of the drugs with a prolonged per-
iod of therapy. New anti-tuberculous agents, especially the
ones with novel mechanisms of action are urgently
required. Curcumin is a naturally occurring yellow pig-
ment obtainable from the rhizomes of perennial herb Cur-
cuma longa Linn., has been shown to act upon several
important molecular targets in malignancy and inflamma-
tory cascades and hence is used to treat various disorders
including arthritis, Crohn’s disease, cardiovascular disor-
ders, psoriasis, cancers, and other pathologies. However,
poor water solubility and unsatisfactory pharmacokinetics
of curcumin necessitate search for new curcumin analogs.
In the present work, we described the synthesis and struc-
tural characterization of highly conjugated curcumin ana-
logs (acetoacetanilide) Knoevenagel condensates, their
Schiff bases, and corresponding copper conjugates.
Method
The anti- M. tuberculosis activities of the compounds
were determined using the MABA assay method.
Results
The minimum inhibitory concentration of copper com-
plexes has been performed against Mycobacterium
tuberculosis strain H37Rv. It is observed that the MIC
values of copper complexes (2-6 µg/ml) are slightly
greater than the drug, ethambutol (1 µg/ml).
Conclusion
Copper complexes have higher anti-mycobacterial activ-
ity than ligands due to the presence of highly conjugated
curcumin analog system containing two azomethine
groups and redox properties of metal. Based on our stu-
dies, we conclude that copper complex may be a pro-
mising candidate against tuberculosis.
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